Principal Financial Group Inc Unity Biotechnology, Inc. Transaction History

Principal Financial Group Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 09, 2022	SELL	$1.3 - $3.17 $13,664 - $33,319	-10,511 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$2.91 - $4.5 $4,958 - $7,668	-1,704 Reduced 13.95%	10,511 $32,000
Q2 2021 Aug 10, 2021	BUY	$4.15 - $6.3 $2,734 - $4,151	659 Added 5.7%	12,215 $56,000
Q1 2021 May 10, 2021	BUY	$5.51 - $9.42 $4,479 - $7,658	813 Added 7.57%	11,556 $69,000
Q4 2020 Feb 08, 2021	BUY	$3.42 - $6.36 $36,741 - $68,325	10,743 New	10,743 $56,000

4.41M

Ticker UBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,036,200
Market Cap $16.1M
Description
Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. The company's lead drug candidate includes UBX1325, which is Phase II clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular d...

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

Stay updated on Principal Financial Group Inc with notifications on news.